This randomized controlled trial evaluated the safety and effectiveness of a testosterone metered-dose transdermal spray in premenopausal women aged 35–46 with decreased sexual satisfaction and low serum-free testosterone levels. A daily dose of 90-μL significantly increased satisfactory sexual events compared to placebo (2.48 vs. 1.70 events, p=0.04). The most common
